A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/48 (2006.01) A61K 38/18 (2006.01) A61K 38/19 (2006.01) A61K 38/20 (2006.01) A61K 39/395 (2006.01) A61P 7/06 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2433933
The present invention relates to a method of using a mammalian gene sequence and polypeptides encoded thereby to treat mammalian hematopoietic disorders. More specifically the present invention relates to methods of using compositions comprising at least one LP82 agonist, LP82 antagonist, LP82 polynucleotide, LP82 polypeptide, and/or LP82 antibody for the prevention and/or treatment of mammalian hematopoietic disorders, including, but not limited to, anemia, leukemia, and hematopoietic conditions caused by bone marrow transplantation or chemo-/radiation therapy.
L'invention concerne une méthode d'utilisation d'une séquence génétique mammifère et des polypeptides codées par celle-ci pour traiter les troubles hématopoïétiques chez les mammifères. Plus précisément, l'invention concerne des méthodes d'utilisation de compositions contenant au moins un agoniste de LP82, un antagoniste de LP82, un polynucléotide de LP82, un polypeptide de LP82, et/ou un anticorps de LP82 pour prévenir et/ou traiter des troubles hématopoïétiques chez les mammifères, notamment l'anémie, la leucémie, et les états hématopoïétiques induits par une greffe de moelle osseuse ou par la chimiothérapie/radiothérapie.
Heuer Josef Georg
Liu Ling
Noblitt Timothy Wayne
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Use of lp82 to treat hematopoietic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of lp82 to treat hematopoietic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of lp82 to treat hematopoietic disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1923400